Come up with a name for your new list and we'll add to it:
GlycArt Biotechnology was acquired by
Roche Holding on July 19, 2005.
GlycArt is a Swiss biotechnology company focused on the development and commercialization of a new generation of antibody products based on its proprietary GlycoMAb technology. GlycoMAb has the potent…